YOLFTbeta
00

Jw Pharmac

001060 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

23,650.00KRW+200.00 (+0.85%)

Price History

Full chart

Market Stats

Previous Close23,450.00
Open23,350.00
Day Range23,350.00 – 24,050.00
52-Week Range20,267.36 – 38,429.66
Volume21.38K
Market Cap609.87B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield2.45%
Beta1.02
50-Day Avg26,347.00
200-Day Avg28,624.75

About

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Young-Sub Shin
  • Employees1.05K
  • HeadquartersJW Gwacheon Tower, 38, Gwacheon-si, South Korea, 13840, Korea
  • Websitehttps://www.jw-pharma.co.kr

Leadership

  • Mr. Young-Sub ShinCEO, Head of Sales & Marketing and Inside Director · b. 1963
  • Sung-Yeol LeeCEO, Head of Product Development & Management and Director
  • Jae-Kwang JeonHead Managing Director and Head of Public Relation · b. 1962
  • Mr. Hyun-seok HanHead of Product Plant · b. 1962
  • Kim Yong KwanDevelopment Head & Internal Director

Financials

Income Statement

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue276.08B298.38B353.92B374.46B394.19B401.62B439.38B431.01B397.08B394.18B412.79B434.35B467.47B502.92B537.18B511.34B547.34B606.58B684.35B748.53B719.38B775.30B
Growth (%)-+8.08%+18.61%+5.81%+5.27%+1.88%+9.40%-1.90%-7.87%-0.73%+4.72%+5.22%+7.62%+7.58%+6.81%-4.81%+7.04%+10.83%+12.82%+9.38%-3.89%+7.77%
Cost of Revenue159.69B163.02B193.67B203.81B215.75B213.46B221.59B274.02B257.41B233.55B244.90B273.73B294.12B314.29B340.14B350.22B369.81B372.21B396.40B412.98B395.88B415.98B
Gross Profit---------144.48B151.27B160.62B173.34B188.63B197.04B161.12B177.53B234.38B287.95B335.54B323.50B359.31B
Gross Margin---------36.65%36.65%36.98%37.08%37.51%36.68%31.51%32.43%38.64%42.08%44.83%44.97%46.35%
Operating Expense---------118.58B133.16B139.10B148.81B166.91B175.46B180.13B178.85B203.18B225.18B234.63B240.77B264.85B
Operating Income41.45B40.85B46.91B46.33B44.40B41.29B51.94B17.53B9.49B25.90B18.11B21.52B24.54B21.72B21.58B-19.01B-1.32B31.20B62.78B100.92B82.73B94.46B
Operating Margin15.02%13.69%13.26%12.37%11.26%10.28%11.82%4.07%2.39%6.57%4.39%4.96%5.25%4.32%4.02%-3.72%-0.24%5.14%9.17%13.48%11.50%12.18%
EBITDA-------------26.32B36.60B-2.71B15.07B43.98B71.59B89.97B111.55B112.01B
EBITDA Margin-------------5.23%6.81%-0.53%2.75%7.25%10.46%12.02%15.51%14.45%
Net Income7.38B10.26B10.89B10.71B12.59B9.08B11.65B--2.24B617.05M1.96B-10.93B-742.47M8.06B-25.28B-15.24B-967.85M31.89B37.01B65.04B61.51B
Net Income Margin2.67%3.44%3.08%2.86%3.19%2.26%2.65%--0.57%0.15%0.45%-2.34%-0.15%1.50%-4.94%-2.78%-0.16%4.66%4.94%9.04%7.93%
R&D-------12.01B26.71B27.98B17.48B16.48B18.00B21.98B21.27B25.22B22.94B19.88B33.74B33.67B36.24B45.45B
R&D as % of Total Revenue-------2.79%6.73%7.10%4.24%3.79%3.85%4.37%3.96%4.93%4.19%3.28%4.93%4.50%5.04%5.86%
Interest Expense000000000000008.69B11.28B7.59B7.34B9.39B12.56B10.03B4.42B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.62%2.21%1.39%1.21%1.37%1.68%1.39%0.57%

Balance Sheet

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets397.46B385.28B385.60B412.00B457.56B477.97B515.85B667.09B603.15B589.37B594.12B613.48B651.08B630.87B593.79B573.21B549.09B633.05B627.97B645.04B604.60B605.27B
Total Liabilities311.99B296.37B284.88B299.40B338.16B358.53B343.37B496.84B439.48B388.63B370.29B388.07B374.76B360.10B333.68B343.12B341.62B444.51B402.21B379.60B275.11B235.90B
Total Equity85.47B88.92B100.72B112.60B119.04B119.44B159.83B170.25B163.66B200.74B223.83B224.83B276.31B270.78B260.11B230.08B207.49B201.19B240.35B265.44B329.49B369.37B
Cash59.90B55.65B29.33B11.70B26.55B19.96B19.25B2.06B2.38B952.06M4.97B8.18B39.25B32.10B30.95B41.86B10.45B33.37B33.90B15.91B10.43B39.23B
Net Debt-------------158.26B144.27B143.27B169.60B209.18B172.54B127.23B56.07B-

Cash Flow

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-45.04B28.74B17.05B15.02B70.25B5.07B-64.21B18.72B7.28B-4.17B6.74B33.45B52.11B55.53B63.05B18.12B56.76B87.16B79.39B96.40B
Investing Cash Flow----------10.18B10.82B-7.35B-8.77B-9.89B-13.92B-21.98B-79.43B-22.87B-18.92B---
Financing Cash Flow---14.48B31.45B9.14B24.76B30.64B--9.96B-14.07B14.68B33.83B-27.87B-41.19B-24.16B-14.01B27.20B-36.91B---
Capital Expenditure016.63B12.61B11.54B27.50B97.76B45.32B9.84B15.35B4.28B6.93B5.56B10.02B7.50B8.64B9.28B12.39B7.47B9.92B40.71B28.14B36.12B
Free Cash Flow-------------22.50B43.76B42.43B48.02B5.22B44.41B46.45B51.25B60.28B
Dividends Paid-1.46B2.82B2.31B3.94B4.03B2.89B2.94B2.04B1.45B1.75B2.69B2.71B5.88B6.51B6.82B6.95B7.15B7.35B8.81B9.67B11.07B
FCF to OCF-------------67.26%83.99%76.42%76.15%28.81%78.24%53.30%64.56%62.53%
Dividend Paid to FCF-------------26.15%14.88%16.06%14.48%136.90%16.55%18.97%18.86%18.36%

Earnings

Report DateNov 11, 2004Mar 2, 2005Aug 16, 2005May 11, 2006Aug 14, 2006Nov 13, 2006Mar 29, 2007Jul 17, 2007Nov 8, 2007Mar 28, 2008Aug 14, 2008May 28, 2009Jul 3, 2009Oct 8, 2009Jan 26, 2010May 14, 2010Aug 13, 2010Nov 12, 2010Mar 2, 2011Apr 8, 2011Jul 8, 2011Oct 13, 2011Feb 29, 2012Apr 6, 2012Jul 6, 2012Oct 11, 2012Feb 27, 2013Apr 5, 2013Jul 5, 2013Oct 10, 2013Feb 26, 2014Apr 4, 2014Jul 4, 2014Oct 9, 2014Feb 25, 2015Apr 3, 2015Aug 17, 2015Nov 13, 2015Feb 25, 2016May 16, 2016Aug 16, 2016Nov 15, 2016Feb 17, 2017May 15, 2017Aug 14, 2017Nov 6, 2017Feb 7, 2018Apr 6, 2018Aug 14, 2018Nov 14, 2018Feb 13, 2019May 15, 2019Aug 15, 2019Nov 14, 2019Mar 25, 2020May 15, 2020Aug 14, 2020Nov 16, 2020May 17, 2021Aug 17, 2021Nov 15, 2021May 10, 2022Aug 16, 2022Nov 9, 2022Feb 8, 2023May 15, 2023Aug 9, 2023Nov 8, 2023Feb 5, 2024May 8, 2024Aug 1, 2024Nov 5, 2024May 7, 2025Jul 30, 2025Nov 4, 2025Dec 31, 2025May 5, 2026Jun 30, 2026
EPS Estimate50.97-3.4452.450.41158.8266.3530.9262.73183.4231.88557.27-33.34--178.8389.2980.5596.16------------------------------------------------606.48663.481061.75577.17527.05614.74769.75-----
EPS Actual76.050.5966.9669.5564.7452.59-30.7876.3741.68-54.98326.06505.58229.84-60.02-61.82342.8087.4250.58-126.1688.5138.44-246.36-434.5215.44-630.44-146.81-534.7738.7250.1130.625.6876.15-243.7728.46215.0522.80-17.4247.7344.4062.74-716.74-192.29236.8835.671089.56232.57-260.26199.58366.4688.82-319.39-203.4361.3247.48-998.00-114.11-353.92123.04178.41-148.83225.23-289.0036.63350.24559.17642.80542.00-742.001014.60816.00346.00807.00714.00-76.821266.64600.751137.701154.59
Surprise49.21%117.15%27.66%16863.41%-59.24%-20.74%-199.55%21.74%-77.28%-272.46%-41.49%1616.44%---134.57%283.92%8.53%-47.40%-------------------------------------------------10.63%-211.83%-4.44%41.38%-34.35%31.27%-7.24%-----
TimingAfter-hoursAfter-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours--After-hoursAfter-hoursAfter-hoursAfter-hours------------------Pre-marketPre-marketPre-marketPre-marketPre-market--Pre-marketPre-market-Pre-market--Pre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market--Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap609.87B
Enterprise Value589.58B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.74
Price / Book1.51
Revenue (TTM)820.86B
Gross Profit (TTM)388.22B
EBITDA127.31B
Profit Margin12.34%
Operating Margin15.02%
Return on Equity27.63%
Return on Assets10.78%
Shares Outstanding22.55M
Shares Float11.60M
Beta1.02
Dividend Yield2.45%
Dividend Rate650.00
Payout Ratio15.63%

Dividends

20261×
650.00Mar 31, 2026
20241×
450.00Dec 27, 2024
20231×
400.00Dec 27, 2023
20221×
356.94Dec 28, 2022
20211×
309.35Dec 29, 2021
20201×
291.59Dec 29, 2020
20191×
291.59Dec 27, 2019
20181×
283.10Dec 27, 2018
20171×
234.85Dec 27, 2017
20161×
205.21Dec 28, 2016
20151×
117.26Dec 29, 2015
20141×
93.06Dec 29, 2014
20131×
88.63Dec 27, 2013
20121×
88.63Dec 27, 2012
20111×
135.06Dec 28, 2011
20101×
187.32Dec 29, 2010
20091×
196.80Dec 29, 2009
20081×
191.07Dec 29, 2008
20071×
176.57Dec 27, 2007
20061×
124.15Dec 27, 2006
20051×
120.54Dec 28, 2005
20041×
163.84Dec 29, 2004
20031×
152.13Dec 29, 2003
20021×
93.62Dec 27, 2002

Stock Splits

  • Dec 27, 20231.02:1
  • Mar 13, 20231.03:1
  • Dec 29, 20211.03:1
  • Dec 29, 20201.03:1
  • Dec 27, 20191.03:1
  • Dec 27, 20181.02:1
  • Dec 27, 20171.02:1
  • Dec 28, 20161.02:1
  • Dec 29, 20151.05:1
  • Dec 29, 20141.05:1
  • Dec 27, 20131.05:1
  • Dec 27, 20121.05:1
  • Dec 28, 20111.05:1
  • Dec 29, 20101.03:1
  • Dec 29, 20091.03:1
  • Dec 29, 20081.03:1
  • Apr 16, 20082:1
  • Jul 2, 20070.637:1
  • Dec 28, 20051.03:1